G-CSF for imatinib-induced neutropenia

Leukemia. 2003 Apr;17(4):805-7. doi: 10.1038/sj.leu.2402869.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Blast Crisis / blood
  • Blast Crisis / drug therapy
  • Clinical Trials, Phase II as Topic
  • Enzyme Inhibitors / adverse effects*
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Follow-Up Studies
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myeloid, Accelerated Phase / blood
  • Leukemia, Myeloid, Accelerated Phase / drug therapy
  • Male
  • Middle Aged
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy*
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Piperazines
  • Pyrimidines
  • Granulocyte Colony-Stimulating Factor
  • Imatinib Mesylate